Functional Systems of Nucleoside Metabolism-Related Enzymes in Drug Response and Disease Biology

Nucleoside metabolism is not a subsidiary step of nucleic acid synthesis, but rather an important metabolic hub that links nucleic acid precursor supply, energy status, replication stress, drug activation, and immune regulation. Through controlling nucleoside uptake, phosphorylation-dependent activation, deamination-mediated inactivation, phosphorolytic recycling, and intercompartmental redistribution, the relevant enzyme systems determine the composition and dynamic balance of intracellular nucleoside and nucleotide pools. Accordingly, the research focus on nucleoside metabolism-related enzymes extends far beyond “several enzymes within a metabolic pathway” and instead centers on key functional nodes governing drug sensitivity, tumor adaptability, viral replication dependence, and immune homeostasis remodeling.

 

Keywords: nucleoside metabolism; salvage synthesis; deoxycytidine kinase; cytidine deaminase; adenosine kinase; purine nucleoside phosphorylase; thymidine kinase; drug response; metabolic reprogramming; disease biology

 

I. Research Boundaries and Functional Framework of Nucleoside Metabolism-Related Enzymes

1.1 Nucleoside metabolism is not isolated from nucleic acid metabolism

(1) Nucleoside metabolism lies at the intersection of uptake, salvage synthesis, and degradative recycling

Intracellular nucleosides are derived from exogenous uptake, reutilization of nucleic acid degradation products, and redistribution following de novo synthesis. Nucleoside-related enzymes do not replace de novo synthesis pathways directly; rather, through salvage synthesis and degradative recycling, they determine precursor utilization efficiency and metabolic flexibility.

(2) Nucleoside metabolism is directly coupled to nucleotide homeostasis

After entering the cell, nucleosides must undergo stepwise phosphorylation by kinases to be converted into nucleotides before entering DNA or RNA synthesis systems. Conversely, nucleotides can also be converted back to nucleosides through reactions mediated by 5′-nucleotidases and related enzymes. Thus, the relationship between nucleosides and nucleotides is not unidirectional, but instead constitutes a continuous bidirectional dynamic equilibrium.

 

1.2 The functions of nucleoside metabolism-related enzymes extend beyond “substrate conversion”

(1) They determine the availability of precursors required for replication and repair

Proliferating cells, damaged cells, and virus-infected cells all exhibit markedly increased demand for nucleoside precursors. The expression and activity states of the relevant enzymes directly determine whether dNTP and NTP pools are sufficient to support replication, transcription, and DNA repair.

(2) They determine whether nucleoside analog drugs can be converted into effective metabolites

Most nucleoside analog drugs must undergo a series of kinase-dependent activation steps after entering the cell before they can inhibit DNA polymerization, block chain elongation, or alter methylation states. Thus, nucleoside metabolism-related enzymes also constitute the drug activation network.

 

1.3 Research on nucleoside metabolism enzymes has pronounced compartmentalization and systemic characteristics

(1) The cytosol and mitochondria have distinct demands for nucleoside supply

Nuclear DNA replication, repair, and RNA synthesis depend primarily on precursor flux between the cytosol and nucleus, whereas mitochondrial DNA maintenance depends on a relatively independent nucleoside salvage system. Therefore, the functional significance of the same class of enzyme differs across compartments.

(2) Transport, activation, and inactivation must be understood as an integrated system

Analysis of a single kinase or a single deaminase is often insufficient to explain drug sensitivity and disease phenotypes. A more rational analytical framework is the integrated functional system of “transport–activation–inactivation–recycling–compartmental utilization.”

 

II. Core Components and Metabolic Steps of Nucleoside Metabolism-Related Enzymes

2.1 Nucleoside transport is the entry step for metabolic utilization

(1) Equilibrative nucleoside transporters determine basal uptake capacity

The ENT family mainly transports nucleosides according to concentration gradients and constitutes a major route by which many natural nucleosides and nucleoside analogs enter cells. Their expression levels can directly affect cellular accessibility to exogenous nucleosides and drugs.

(2) Concentrative nucleoside transporters enhance uptake of specific substrates

The CNT family mediates active uptake through ion gradients and displays higher selectivity for certain pyrimidine and purine nucleosides. Differences in transporter profiles can markedly alter cellular responses to drugs and nutrient substrates.

 

2.2 Kinase systems are responsible for nucleoside activation and salvage synthesis

(1) Thymidine kinases and deoxycytidine kinase constitute key activation nodes

TK1 and TK2 mainly participate in thymidine-related salvage synthesis, whereas dCK is the key enzyme responsible for activation of multiple deoxynucleosides and nucleoside analogs. Together, they determine the efficiency with which deoxynucleosides enter the DNA precursor pool.

(2) Adenosine kinase and uridine-cytidine kinases connect ribonucleoside utilization

ADK catalyzes the conversion of adenosine toward AMP, whereas UCK1/2 activate uridine and cytidine. These steps not only maintain RNA precursor supply, but also influence adenosine homeostasis and metabolic signaling.

 

2.3 Deamination and phosphorolysis systems determine the direction of nucleoside inactivation and recycling

(1) Deaminases control the chemical fate of nucleosides

Cytidine deaminase and adenosine deaminase alter nucleoside structure through deamination, thereby redirecting them into different metabolic branches. These reactions participate in physiological metabolism and also constitute important mechanisms of nucleoside analog drug inactivation.

(2) Nucleoside phosphorylases mediate reversible degradation and reutilization

Purine nucleoside phosphorylase, thymidine phosphorylase, and uridine phosphorylase can degrade nucleosides into bases and sugar-1-phosphate, thereby channeling them into reutilization or further catabolic pathways.

 

2.4 Compartment-specific kinase systems determine mitochondrial nucleic acid homeostasis

(1) TK2 and DGUOK maintain mitochondrial deoxynucleoside salvage

Mitochondrial DNA replication depends on a specific salvage synthesis system. TK2 and DGUOK participate in activation of substrates such as thymidine and deoxyguanosine, and are therefore directly linked to mitochondrial DNA homeostasis.

(2) Compartmental imbalance can be translated into organ-specific disease phenotypes

If mitochondrial nucleoside activation is impaired, high-energy-demand tissues are more likely to develop mtDNA depletion, oxidative phosphorylation defects, and organ functional decline.

Table 1. Key Nucleoside Metabolism-Related Enzymes and Their Functional Positioning

 

Enzyme Name	Major Substrates	Major Metabolic Step	Core Functional Positioning	Related Biological Significance
dCK	Deoxycytidine, deoxyadenosine, deoxyguanosine, and multiple analogs	Salvage synthesis, initial phosphorylation	Key enzyme for deoxynucleoside activation	Determines sensitivity to multiple antitumor nucleoside analogs
TK1	Thymidine	Cytosolic salvage synthesis	Thymidine activation associated with DNA replication	Closely associated with proliferative activity
TK2	Thymidine, deoxycytidine	Mitochondrial salvage synthesis	Mitochondrial deoxynucleoside activation	Maintains mtDNA homeostasis
ADK	Adenosine	Ribonucleoside activation	Regulates adenosine reutilization and adenosine homeostasis	Connects metabolism with immune regulation
UCK1/UCK2	Uridine, cytidine	Ribonucleoside salvage synthesis	Pyrimidine nucleoside activation	Determines efficiency of RNA precursor utilization
CDA	Cytidine, deoxycytidine, multiple cytidine analogs	Deamination-mediated inactivation	Controls degradation of cytidine-type substrates	Influences responses to drugs such as gemcitabine and cytarabine
ADA	Adenosine, deoxyadenosine	Deamination-mediated degradation	Regulates adenosine and deoxyadenosine burden	Closely associated with immune homeostasis and lymphocyte function
PNP	Purine nucleosides	Phosphorolytic degradation and recycling	Catalyzes cleavage of purine nucleosides	Influences T-cell metabolism and immune development
TYMP/TP	Thymidine, deoxyuridine	Phosphorolytic metabolism	Thymidine-related degradation and redistribution	Associated with angiogenesis and local metabolic remodeling
DGUOK	Deoxyguanosine, deoxyadenosine	Mitochondrial salvage synthesis	Activation of mitochondrial purine deoxynucleosides	Maintains mitochondrial nucleic acid supply

 

III. Functional Systems of Nucleoside Metabolism-Related Enzymes in Drug Response

3.1 Nucleoside analog drugs depend on enzymatic activation

(1) Initial phosphorylation is often the rate-limiting step determining drug efficacy

Most nucleoside analogs are not directly active after entering the cell, but must first be converted into monophosphate forms by dCK, TK, UCK, or related enzymes, and then further converted into diphosphate and triphosphate forms. If initial phosphorylation is restricted, the drug may fail to form effective active metabolites even after cellular uptake.

(2) Different drugs exhibit different dependencies on different kinase systems

Drugs such as cytarabine, gemcitabine, fludarabine, and cladribine depend more strongly on dCK-mediated activation, whereas some antiviral nucleoside analogs may depend on viral kinases or host kinase systems. Thus, drug sensitivity is not merely a matter of cytotoxicity, but of enzymatic compatibility.

 

3.2 Inactivating enzyme systems determine stratification of resistance and toxicity

(1) Increased deaminase activity can reduce effective drug exposure

CDA can rapidly reduce the effective concentration of cytidine-type drugs, so its high expression is often associated with drug resistance. Conversely, insufficient CDA activity may lead to excessively high effective drug exposure and increased toxicity risk.

(2) Nucleoside phosphorylases and reverse metabolic pathways can also reshape drug fate

Certain drug metabolites may be further degraded, recycled, or transformed, thereby weakening sustained inhibitory effects. Therefore, interpretation of drug response cannot remain at the level of “high or low kinase expression,” but must also integrate inactivation and recycling networks.

 

3.3 The integrated transport–activation–inactivation system determines patterns of drug response

(1) Insufficient transport can produce apparent resistance

If nucleoside transporter expression is inadequate, the initial intracellular drug load is limited. Under such conditions, even normal expression of activating enzymes may still be associated with insufficient drug efficacy.

(2) Imbalance between activation and inactivation determines the intracellular pool of effective metabolites

What truly determines drug intensity is not the expression level of a single enzyme, but the intracellular pool of effective drug metabolites shaped jointly by transport, activation, inactivation, and efflux.

 

IV. Nucleoside Metabolism-Related Enzymes and Tumor Biology

4.1 Tumor cells frequently depend on salvage synthesis to improve metabolic efficiency

(1) High proliferative states increase demand for nucleoside precursors

Tumor cells require continuous supply of precursors for DNA replication and RNA synthesis. Therefore, in addition to de novo synthesis, they often increase nucleoside utilization efficiency through salvage synthesis, thereby reducing metabolic cost and enhancing survival advantage.

(2) Enhancement of salvage pathways can generate metabolic adaptability

Under nutrient limitation, hypoxia, or drug pressure, salvage synthesis can serve as an important alternative route by which tumor cells maintain nucleic acid precursor supply. Upregulation of the relevant kinases and phosphorylases often indicates stronger metabolic adaptability.

 

4.2 Nucleoside metabolism enzymes influence genomic stability

(1) dNTP pool imbalance increases replication stress

If activation, recycling, and degradation of nucleosides become imbalanced, abnormal dNTP pool proportions may induce replication fork stalling, increased mismatch frequency, and enhanced DNA damage responses.

(2) Abnormal precursor supply can alter repair efficiency

DNA repair depends not only on repair enzyme systems, but also on local and global precursor availability. Accordingly, changes in nucleoside metabolism-related enzymes can reshape precursor pools and thereby influence repair capacity and mutation accumulation rates.

 

4.3 Nucleoside metabolism enzymes can serve as tumor stratification markers and intervention targets

(1) Expression profiles can be used for stratification of drug sensitivity

The expression and activity states of enzymes such as dCK, CDA, UCK2, and NT5C2 can be used to infer response trends to nucleoside analog drugs.

(2) Metabolic nodes can be used for design of combination therapy

If salvage synthesis and inactivation pathways are specifically reprogrammed within the same tumor, coordinated intervention targeting key kinases, deaminases, and transporters is more likely to yield mechanistically coherent therapeutic benefit.

 

V. Roles of Nucleoside Metabolism-Related Enzymes in Immunity, Inflammation, and Infection

5.1 The adenosine metabolic axis is an important component of immune regulation

(1) Adenosine is not merely a metabolic intermediate

Adenosine is both a product of nucleoside metabolism and an important immunoregulatory molecule. By controlling the fate of adenosine after its formation, ADK and ADA influence local adenosine concentration and the strength of related receptor signaling.

(2) Changes in adenosine homeostasis can remodel inflammatory thresholds

If adenosine clearance and reutilization capacities change, immune cell activation thresholds, the extent of inflammatory amplification, and tissue-protective responses can all be shifted. Accordingly, adenosine metabolism-related enzymes are nodes of metabolism-signal coupling rather than simple degradative enzymes.

 

5.2 Hereditary enzyme deficiencies can directly cause immune pathology

(1) ADA deficiency impairs lymphocyte survival

When deoxyadenosine and its related metabolites accumulate, lymphocytes are highly sensitive to metabolic toxicity. Thus, ADA deficiency can cause severe defects in immune development.

(2) PNP deficiency affects the T-cell system

Abnormal purine nucleoside phosphorolysis can cause accumulation of specific nucleoside metabolites and preferentially impair T-cell-related immune functions. This indicates that purine nucleoside degradation is not a peripheral process, but a foundational layer of immune homeostasis.

 

5.3 Viral replication and antiviral drug efficacy both depend on nucleoside metabolism systems

(1) Viral replication depends on host- or virus-derived nucleoside activation systems

Viral amplification requires large amounts of nucleic acid precursors and therefore exhibits pronounced dependence on the host-cell nucleoside metabolism network. Some viruses also encode their own kinase systems to enhance activation efficiency of specific nucleoside analog drugs.

(2) Antiviral nucleoside analog drugs depend on selective activation

Drug design often exploits differences between viral and host kinase substrate preferences to achieve relatively selective inhibition. Thus, nucleoside metabolism enzymes determine not only whether a drug is effective, but also the basis of its selectivity.

 

VI. Compartmentalized Nucleoside Metabolism and Metabolism-Signal Coupling

6.1 Cytosolic and mitochondrial nucleoside metabolism are not completely overlapping

(1) Cytosolic salvage synthesis mainly serves nuclear DNA replication and RNA synthesis

TK1, dCK, and UCK participate more extensively in cytosolic and nuclear precursor supply and determine the rapid response capacity of proliferating cells to nucleic acid precursor demand.

(2) Mitochondrial nucleoside salvage mainly serves mtDNA homeostasis

The functions of enzymes such as TK2 and DGUOK are more directly associated with mitochondrial DNA replication, repair, and copy number maintenance. These compartmental differences mean that similar nucleoside metabolic abnormalities can manifest as distinctly different disease spectra.

 

6.2 Changes in nucleoside metabolism can be translated into signaling-layer consequences

(1) Changes in precursor pools can trigger replication stress and stress signaling

Insufficient nucleoside activation, dNTP imbalance, or excessive degradative burden can all induce DNA damage responses, activation of replication checkpoints, and cell-cycle reprogramming.

(2) Adenosine homeostasis can be translated into immune and hypoxia-related signaling

Changes in the balance among adenosine generation, reuptake, and degradation can influence inflammation, angiogenesis, and tissue adaptation through receptor-mediated and transcriptional networks.

 

6.3 Nucleoside metabolism enzymes are typical metabolism–signal interface molecules

(1) Their upstream regulation is controlled by nutrient status, hypoxia, and proliferative state

Under conditions of high proliferation, hypoxia, inflammation, and therapeutic stress, cells can actively reconfigure the expression profile of nucleoside metabolism-related enzymes to adapt to precursor demand and stress requirements.

(2) Their downstream effects can feed back into cell fate decisions

Once nucleoside metabolic imbalance progresses to the level of replication stress, DNA damage, and inflammatory signaling, cellular outcomes may shift from adaptive growth toward senescence, apoptosis, drug resistance, or immune escape.

 

VII. Key Pathways, Targets, and Evaluation Metrics in Research and Translation

7.1 Major research pathways

(1) Nucleoside uptake and salvage synthesis pathways

The focus is on ENT/CNT transport, dCK/TK/UCK-mediated activation, and efficiency of nucleotide precursor formation.

(2) Deamination and phosphorolytic degradation pathways

The focus is on the effects of CDA, ADA, PNP, TYMP, and related enzymes on nucleoside degradation and drug inactivation.

(3) Compartmentalized nucleoside metabolism pathways

The focus is on how cytosolic and mitochondrial salvage systems differentially influence nuclear DNA and mtDNA homeostasis.

(4) Nucleoside metabolism–drug response coupling pathways

The focus is on how transport, activation, inactivation, and metabolic pool balance together determine nucleoside analog efficacy and resistance.

 

7.2 Key targets

(1) Drug activation targets

These include dCK, TK1, TK2, and UCK1/2, and are primarily associated with activation efficiency of nucleoside analogs.

(2) Drug inactivation and degradation targets

These include CDA, ADA, PNP, TYMP, and related reverse metabolic enzymes, and are primarily associated with resistance and toxicity differences.

(3) Compartmental homeostasis targets

These include TK2 and DGUOK, and are primarily associated with mitochondrial nucleic acid homeostasis and tissue-specific pathology.

 

7.3 Common evaluation metrics

(1) Metabolic-level metrics

① Abundance of nucleoside and nucleotide pools.

② dNTP pool ratios.

③ Levels of adenosine, deoxyadenosine, and related metabolites.

④ Concentrations of active drug metabolites.

⑤ Salvage synthesis flux.

(2) Molecular-level metrics

① Expression levels of dCK, CDA, ADA, PNP, TK1, TK2, and related enzymes.

② Measurement of key enzyme activity.

③ Nucleoside transporter expression profiles.

④ DNA damage and replication stress markers.

⑤ Mitochondrial DNA copy number.

(3) Phenotypic-level metrics

① Drug sensitivity.

② Cell proliferation and cell-cycle status.

③ Apoptotic and senescent phenotypes.

④ Functional state of immune cells.

⑤ Viral replication burden or related response indicators.

Table 2. Pathways, Targets, and Evaluation Metrics in Research on Nucleoside Metabolism-Related Enzymes

 

Research Direction	Major Pathway	Key Targets	Common Evaluation Metrics
Nucleoside uptake and salvage synthesis	ENT/CNT transport and dCK/TK/UCK activation axis	ENT1, CNT family, dCK, TK1, TK2, UCK1/2	Nucleoside uptake rate, dNTP pool, kinase activity
Deamination and drug inactivation	CDA- and ADA-related deamination axis	CDA, ADA	Drug metabolite concentration, deamination activity, cytotoxic response
Purine nucleoside degradation and immune homeostasis	PNP-, ADA-, and adenosine-related metabolic axis	PNP, ADA, ADK	Adenosine level, immune cell function, metabolic burden
Mitochondrial nucleoside salvage	TK2- and DGUOK-related pathways	TK2, DGUOK	mtDNA copy number, mitochondrial function, tissue injury markers
Drug response and resistance	Integrated transport–activation–inactivation network	dCK, CDA, NT5C2, transporters	Drug sensitivity, active metabolite level, resistance phenotype

 

VIII. Aladdin-Related Products

 

Name	CAS No.	Experimental Step	Key Use	Notes for Use
Adenosine	58-61-7	Adenosine homeostasis and immune regulation studies	Used to construct models related to adenosine metabolism, adenosine receptor signaling, and adenosine kinase	Suitable for combined analysis with ADK and ADA activity, as well as receptor antagonist/agonist systems
Cytidine	65-46-3	Pyrimidine nucleoside salvage synthesis studies	Used to evaluate cytidine uptake, CDA-mediated deamination, and UCK-related activation capacity	Suitable for use together with cytidine deaminase inhibition or nucleoside uptake assays
Uridine	58-96-8	RNA precursor supply and salvage synthesis studies	Used to analyze uridine uptake, UCK1/2 activation, and ribonucleoside metabolic adaptation	Suitable for combined use with transporter analysis, ribonucleotide pool measurements, and RNA synthesis readouts
Inosine	58-63-9	Purine nucleoside catabolism and immune metabolism studies	Used to evaluate PNP-related degradation, purine recycling, and T-cell metabolic responses	Suitable for parallel detection with ADA, PNP, and adenosine-related metabolites
Guanosine	118-00-3	Purine nucleoside salvage and catabolism studies	Used to evaluate purine nucleoside uptake, phosphorolytic recycling, and nucleoside pool redistribution	Suitable for combined use with PNP activity, base salvage, and nucleotide pool analysis
Thymidine	50-89-5	DNA precursor supply and thymidine kinase studies	Used to evaluate TK1/TK2 activation capacity and dTTP pool dynamics	Suitable for combined use with proliferation models, DNA replication stress, and mitochondrial nucleoside salvage studies
2'-Deoxycytidine	951-77-9	dCK substrate and deoxynucleoside salvage studies	Used to analyze dCK activation efficiency and deoxynucleoside precursor supply capacity	Suitable for combined use with studies on responses to cytidine analog drugs such as cytarabine and gemcitabine
2'-Deoxyadenosine	958-09-8	ADA and deoxypurine metabolism studies	Used to construct models for ADA-related metabolic toxicity and immune deficiency	Suitable for combined use with ADA inhibition, purine metabolic burden, and lymphocyte phenotype analysis
2'-Deoxyguanosine	961-07-9	Mitochondrial nucleoside salvage and DGUOK studies	Used to evaluate mitochondrial purine deoxynucleoside activation and mtDNA precursor supply capacity	Suitable for combined analysis with DGUOK, TK2, and mitochondrial functional readouts
2'-Deoxyuridine	951-78-0	Thymidine/uridine metabolic bypass studies	Used to analyze deoxypyrimidine nucleoside salvage, TYMP-related degradation, and metabolic redistribution	Suitable for combined use with thymidine phosphorylase, mitochondrial nucleoside homeostasis, and dNTP balance studies
Cytarabine	147-94-4	Nucleoside analog drug response studies	A classic dCK-dependent cytidine analog used to analyze drug activation and resistance mechanisms	Drug efficacy should be interpreted with emphasis on dCK, CDA, ENT transporters, and active metabolite formation efficiency
Gemcitabine	95058-81-4	Antitumor nucleoside analog response studies	Used to study dCK-mediated activation, CDA-mediated inactivation, and intracellular drug pool balance	Suitable for combined use with ribonucleotide reductase, replication stress, and cell-cycle arrest readouts
Fludarabine	21679-14-1	Purine analog pharmacology studies	Used to analyze activation and cytotoxic effects of purine nucleoside analogs within the salvage synthesis system	Suitable for combined use with dCK, ADA, PNP, and apoptosis readouts
Cladribine	4291-63-8	Deoxyadenosine analog pharmacology studies	Used to study dCK-dependent activation and lymphocyte cytotoxic responses	Better suited for combined use with dCK, ADA, and immune cell functional models
Nelarabine	121032-29-9	T-cell-related nucleoside analog studies	Used to analyze activation and toxic responses of deoxyguanosine analogs in lymphoid malignancies	Suitable for combined use with dCK, ADA, DGUOK, and cell death readouts
Floxuridine	50-91-9	Pyrimidine metabolism and DNA synthesis studies	Used to analyze activation of pyrimidine nucleoside analogs, interference with dTMP metabolism, and replication inhibition	Suitable for combined analysis with thymidine metabolism, TK activity, and DNA replication stress readouts
5-Fluorouridine	316-46-1	RNA precursor interference studies	Used to study the effects of pyrimidine nucleoside analogs on RNA metabolism and nucleoside salvage pathways	Suitable for combined use with UCK, RNA incorporation, and transcription inhibition indicators
5-Azacytidine	320-67-2	Nucleoside analog and epigenetic studies	Used to study the link between nucleoside metabolic activation and DNA/RNA methylation intervention	Suitable for combined use with UCK, nucleic acid incorporation, and methylation readouts
Decitabine	2353-33-5	Demethylation and drug response studies	Used to study the effects of activated deoxynucleoside analogs on DNA methylation and replication responses	Better suited for actively proliferating cell systems and should be used with careful control of cytotoxicity and dose window
Pentostatin	53910-25-1	ADA inhibition studies	Used to inhibit adenosine deaminase activity and analyze deoxyadenosine accumulation and immune-metabolic consequences	Suitable for combined use with ADA substrate burden, lymphocyte toxicity, and purine metabolism readouts
Dipyridamole	58-32-2	Nucleoside transport regulation studies	Commonly used to inhibit equilibrative nucleoside transporters and evaluate the effects of nucleoside uptake on drug response and metabolic pools	Suitable for combined use with ENT1/ENT2, nucleoside uptake assays, and drug sensitivity analysis
Tipiracil	183204-72-0	Thymidine phosphorylase-related studies	Used to inhibit TYMP/TP activity and analyze thymidine degradation, local metabolic remodeling, and drug synergistic effects	Suitable for combined use with thymidine, 2'-deoxyuridine, and TYMP expression analysis
6-Mercaptopurine	50-44-2	Purine metabolism and drug response studies	Used to analyze the effects of purine salvage synthesis, drug activation, and catabolic balance on inhibition of cell proliferation	Suitable for combined use with HGPRT-related metabolism, the PNP pathway, and drug sensitivity readouts
6-Thioguanine	154-42-7	Purine analog pharmacology studies	Used to study mechanisms of purine analog incorporation, nucleic acid damage, and cytotoxicity	Suitable for combined use with purine salvage synthesis, DNA damage, and apoptosis indicators
Adenosine deaminase	9026-93-1	Enzyme activity measurement and substrate conversion studies	Used to construct adenosine/deoxyadenosine deamination reaction systems and evaluate ADA-related metabolic capacity	Suitable for use together with adenosine, deoxyadenosine, and inhibitor systems
Cytidine deaminase	9001-54-1	Drug inactivation mechanism studies	Used to construct deamination-mediated inactivation systems for cytidine and cytidine analogs	Suitable for combined use with cytidine, deoxycytidine, cytarabine, and gemcitabine
Deoxycytidine kinase	9027-60-5	In vitro drug activation systems	Used to evaluate the efficiency of initial phosphorylation of deoxycytidine and its analogs	Suitable for combined use with ATP, nucleoside substrates, and downstream monophosphate product detection
Purine nucleoside phosphorylase	9030-21-1	Purine nucleoside degradation studies	Used to construct purine nucleoside phosphorolysis systems and analyze nucleoside cleavage and recycling capacity	Suitable for combined use with inosine, guanosine, deoxyguanosine, and inhibitors
Ribose	50-69-1	Supporting substrate studies for nucleoside metabolism	Used to analyze the effects of ribose supply on nucleoside resynthesis and energy metabolism	Better suited for use with PRPP, salvage synthesis, and nucleotide pool studies

 

The functions of nucleoside metabolism-related enzymes in drug response and disease biology are not limited to nucleic acid precursor supply, but instead extend throughout metabolic adaptation, replication stress, immune homeostasis, viral replication, and drug activation. Research on this system should be conducted within the unified framework of “transport–activation–inactivation–recycling–compartmental homeostasis–functional consequence,” so that the true biological significance of nucleoside metabolism enzyme networks in disease development, therapeutic response, and mechanistic stratification can be accurately understood.

 

For more related articles, please see below:

[1] Application of nucleoside pharmaceutical intermediates